Literature DB >> 6259308

Defective oxidative metabolic responses of neutrophils from stressed neonates.

A O Shigeoka, R P Charette, M L Wyman, H R Hill.   

Abstract

Oxidative metabolic responses of polymorphonuclear leukocytes were assessed in 24 stressed neonates and 22 well, term infants utilizing particulate and soluble stimuli. Stressed neonatal PMNs demonstrated a depressed CL response to zymosan, whereas O2- production for both normal and stressed PMNs of neonates was significantly elevated compared to that in PMNs from adults. These results were not ascribable to phagocytosis since it was comparable in all groups using radiolabeled bacteria. Stressed neonates' PMN responses to soluble stimuli were significantly elevated when compared with those from well neonate and adult controls. Enhanced responses were most prominent in the most severely stressed infants. Treatment of neonates' PMNs with the antioxidants vitamin E and DHB partially corrected the abnormalities, suggesting peroxidative damage to the PMN membrane had occurred. The oxidative metabolic abnormalities of neonates' PMNs are consistent with either a defect in HMPS activity, a defect in functioning of the later portions of the respiratory burst, or a stimulus-specific abnormality in respiratory burst activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259308     DOI: 10.1016/s0022-3476(81)80701-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

Review 1.  Photon emission of phagocytes in relation to stress and disease.

Authors:  E M Lilius; P Marnila
Journal:  Experientia       Date:  1992-12-01

2.  Alterations in complement-induced shape change and stimulus-specific superoxide anion generation by neonatal calf neutrophils.

Authors:  W Holden; D O Slauson; R D Zwahlen; M M Suyemoto; M Doré; N R Neilsen
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

Review 3.  Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review.

Authors:  J Evdoridou; E Roilides; E Bibashi; G Kremenopoulos
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

4.  Functional capacity of marginated and bone marrow reserve granulocytes.

Authors:  R W Steele; C R Steele; N S Pilkington; R K Charlton
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

5.  Effect of fibronectin on adherence of neutrophils from newborn infants.

Authors:  M C Harris; J Levitt; S D Douglas; J S Gerdes; R A Polin
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 6.  Assessment of neutrophil function--II. Laboratory tests of neutrophil function.

Authors:  E N Wardle
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

7.  Mode of delivery directs the phagocyte functions of infants for the first 6 months of life.

Authors:  M M Grönlund; J Nuutila; L Pelto; E M Lilius; E Isolauri; S Salminen; P Kero; O P Lehtonen
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

8.  Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome.

Authors:  Sun Kwon Kim; Roberto Romero; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Pooja Mittal; Offer Erez; Edi Vaisbuch; Francesca Gotsch; Percy Pacora; Lami Yeo; Maria Teresa Gervasi; Ronald F Lamont; Bo Hyun Yoon; Sonia S Hassan
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

Review 9.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.

Authors:  Joyce M Koenig; William J Keenan
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.